Pharmacogenetics - JoVE Visualize

Showing results (271-280 of 830) with videos related to

Pageof 83

Sort By:

Pharmacogenetics|May 10, 2000

Relationship between NAT1 genotype and phenotype in a Japanese populationM Yang, T Katoh, R Delongchamp, et al.

Pharmacogenetics|May 10, 2000

Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytesS Z Abdel-Rahman, S A Salama, W W Au, et al.

Pharmacogenetics|May 10, 2000

Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthmaL Yan, R E Galinsky, J A Bernstein, et al.

Pharmacogenetics|April 26, 2000

Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individualsH G Xie, C M Stein, R B Kim, et al.

Pharmacogenetics|February 18, 1999

Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reactionL Bathum, I Johansson, M Ingelman-Sundberg, et al.

Pharmacogenetics|February 18, 1999

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.

Pharmacogenetics|October 19, 2000

Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French populationI Stücker, M Jacquet, I de Waziers, et al.

Pharmacogenetics|February 24, 2001

Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compoundsW F Li, L G Costa, R J Richter, et al.

Pharmacogenetics|December 12, 2001

Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studiesR R Freimuth, B Eckloff, E D Wieben, et al.

Pharmacogenetics|February 28, 2001

Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controlsY M Tang, B L Green, G F Chen, et al.

Pageof 83

Showing results (271-280 of 830) with videos related to

Sort By:

Pageof 83

Pharmacogenetics|May 10, 2000

Relationship between NAT1 genotype and phenotype in a Japanese populationM Yang, T Katoh, R Delongchamp, et al.

Pharmacogenetics|May 10, 2000

Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytesS Z Abdel-Rahman, S A Salama, W W Au, et al.

Pharmacogenetics|May 10, 2000

Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthmaL Yan, R E Galinsky, J A Bernstein, et al.

Pharmacogenetics|April 26, 2000

Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individualsH G Xie, C M Stein, R B Kim, et al.

Pharmacogenetics|February 18, 1999

Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reactionL Bathum, I Johansson, M Ingelman-Sundberg, et al.

Pharmacogenetics|February 18, 1999

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.

Pharmacogenetics|October 19, 2000

Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French populationI Stücker, M Jacquet, I de Waziers, et al.

Pharmacogenetics|February 24, 2001

Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compoundsW F Li, L G Costa, R J Richter, et al.

Pharmacogenetics|December 12, 2001

Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studiesR R Freimuth, B Eckloff, E D Wieben, et al.

Pharmacogenetics|February 28, 2001

Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controlsY M Tang, B L Green, G F Chen, et al.

Pageof 83